皮质激素-话题@MedSci

#皮质激素#

263篇内容 | 2400人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1600375, encodeId=f49716003e536, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Arthritis Rheumatol：狄诺塞麦与利塞膦酸盐对糖皮质激素诱导的骨质疏松症疗效的比较, objectType=article, longId=161683, objectId=1c1d161683f3, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1c1d161683f3, replyNumber=0, likeNumber=43, createdTime=2019-03-07, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1c1d161683f3, moduleTitle=Arthritis Rheumatol：狄诺塞麦与利塞膦酸盐对糖皮质激素诱导的骨质疏松症疗效的比较, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1c1d161683f3)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600374, encodeId=9a8d16003e4d7, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=2019 BSH更佳实践指南：接受类固醇治疗的免疫血小板减少症患者糖皮质激素性骨质疏松症的预防, objectType=article, longId=159389, objectId=7f23159389aa, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=7f23159389aa, replyNumber=0, likeNumber=15, createdTime=2019-02-03, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=7f23159389aa, moduleTitle=2019 BSH更佳实践指南：接受类固醇治疗的免疫血小板减少症患者糖皮质激素性骨质疏松症的预防, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=7f23159389aa)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600373, encodeId=38ce16003e33c, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=2018 韩国指南：糖皮质激素性骨质疏松的预防和治疗, objectType=article, longId=157020, objectId=505c15e020fc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=505c15e020fc, replyNumber=0, likeNumber=17, createdTime=2018-12-31, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=505c15e020fc, moduleTitle=2018 韩国指南：糖皮质激素性骨质疏松的预防和治疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=505c15e020fc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600372, encodeId=b7c116003e22b, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Biochem Biophys Res Commun：CircUSP45通过PTEN/AKT信号通路海绵miR-127-5p抑制糖皮质激素诱导的股骨头坏死, objectType=article, longId=156719, objectId=04cf156e196a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=04cf156e196a, replyNumber=0, likeNumber=53, createdTime=2018-12-28, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=04cf156e196a, moduleTitle=Biochem Biophys Res Commun：CircUSP45通过PTEN/AKT信号通路海绵miR-127-5p抑制糖皮质激素诱导的股骨头坏死, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=04cf156e196a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600371, encodeId=713c16003e180, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=常见风湿病中糖皮质激素的正确用法，你都知道吗？, objectType=article, longId=156584, objectId=cf3a156584e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cf3a156584e2, replyNumber=0, likeNumber=58, createdTime=2018-12-26, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cf3a156584e2, moduleTitle=常见风湿病中糖皮质激素的正确用法，你都知道吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cf3a156584e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600370, encodeId=70d116003e026, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Kidney Int：微小病变肾病综合征：低剂量糖皮质激素+麦考酚钠是否优于标准方案？, objectType=article, longId=156117, objectId=0e9615611e5f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0e9615611e5f, replyNumber=0, likeNumber=64, createdTime=2018-12-20, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0e9615611e5f, moduleTitle=Kidney Int：微小病变肾病综合征：低剂量糖皮质激素+麦考酚钠是否优于标准方案？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0e9615611e5f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600369, encodeId=2a7916003690f, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=J Thromb Haemost：缺血性卒中患者使用糖皮质激素心血管事件风险知多少, objectType=article, longId=155424, objectId=5a66155424ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5a66155424ee, replyNumber=0, likeNumber=53, createdTime=2018-12-10, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5a66155424ee, moduleTitle=J Thromb Haemost：缺血性卒中患者使用糖皮质激素心血管事件风险知多少, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5a66155424ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600368, encodeId=f261160036868, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Ann Pharmacother：COPD急性加重：全身性糖皮质激素要联合ICS吗？, objectType=article, longId=155422, objectId=33b21554225d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=33b21554225d, replyNumber=0, likeNumber=68, createdTime=2018-12-10, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=33b21554225d, moduleTitle=Ann Pharmacother：COPD急性加重：全身性糖皮质激素要联合ICS吗？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=33b21554225d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600367, encodeId=a31a160036ed3, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Health Technol Assess：儿童中耳炎听力受损口服糖皮质激素治疗有待推敲！, objectType=article, longId=155115, objectId=fb6d1551152d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb6d1551152d, replyNumber=0, likeNumber=69, createdTime=2018-12-06, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb6d1551152d, moduleTitle=Health Technol Assess：儿童中耳炎听力受损口服糖皮质激素治疗有待推敲！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb6d1551152d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600366, encodeId=4e761600366e2, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=JAMA：COPD急性加重控制病情低剂量茶碱可协助吸入性糖皮质激素？, objectType=article, longId=154544, objectId=bc7215454490, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=bc7215454490, replyNumber=0, likeNumber=57, createdTime=2018-11-29, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=bc7215454490, moduleTitle=JAMA：COPD急性加重控制病情低剂量茶碱可协助吸入性糖皮质激素？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=bc7215454490)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600365, encodeId=42501600365ae, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=JCO：PD-1/PD-L1抑制剂初始治疗NSCLC 糖皮质激素让抗癌神药部分失效, objectType=article, longId=154370, objectId=61761543e050, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=61761543e050, replyNumber=0, likeNumber=92, createdTime=2018-11-27, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=61761543e050, moduleTitle=JCO：PD-1/PD-L1抑制剂初始治疗NSCLC 糖皮质激素让抗癌神药部分失效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=61761543e050)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600364, encodeId=3cf9160036466, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=J Bone Miner Res：炎症疾病患者：糖皮质激素剂量极小能否逃脱骨折风险？, objectType=article, longId=154203, objectId=86e015420318, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86e015420318, replyNumber=0, likeNumber=62, createdTime=2018-11-24, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86e015420318, moduleTitle=J Bone Miner Res：炎症疾病患者：糖皮质激素剂量极小能否逃脱骨折风险？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=86e015420318)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600363, encodeId=1f07160036315, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Diabetic Med：尿蛋白质组学和盐皮质激素受体拮抗预防2型糖尿病患者的糖尿病肾病, objectType=article, longId=153681, objectId=1cf71536815b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cf71536815b, replyNumber=0, likeNumber=60, createdTime=2018-11-18, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cf71536815b, moduleTitle=Diabetic Med：尿蛋白质组学和盐皮质激素受体拮抗预防2型糖尿病患者的糖尿病肾病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cf71536815b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600362, encodeId=69e01600362a0, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Sci Rep：糖皮质激素能够诱导前列腺癌细胞的治疗抗性相关的应激癌蛋白, objectType=article, longId=151505, objectId=d2d415150586, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d2d415150586, replyNumber=0, likeNumber=99, createdTime=2018-10-23, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d2d415150586, moduleTitle=Sci Rep：糖皮质激素能够诱导前列腺癌细胞的治疗抗性相关的应激癌蛋白, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d2d415150586)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600361, encodeId=e164160036141, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=2018 SOGC临床实践指南：产前糖皮质激素治疗改善胎儿结局（No.364）, objectType=article, longId=150978, objectId=99201509e8bd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=99201509e8bd, replyNumber=0, likeNumber=37, createdTime=2018-10-15, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=99201509e8bd, moduleTitle=2018 SOGC临床实践指南：产前糖皮质激素治疗改善胎儿结局（No.364）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=99201509e8bd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600360, encodeId=eb261600360d0, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Laryngoscope：鼻用糖皮质激素不能导致眼部变化, objectType=article, longId=150589, objectId=0d43150589df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0d43150589df, replyNumber=0, likeNumber=78, createdTime=2018-10-10, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0d43150589df, moduleTitle=Laryngoscope：鼻用糖皮质激素不能导致眼部变化, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0d43150589df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600359, encodeId=238b160035908, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Ann Rheum Dis ：托珠单抗对糖皮质激素难治性成人still病的疗效, objectType=article, longId=150335, objectId=2ffe15033567, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2ffe15033567, replyNumber=0, likeNumber=63, createdTime=2018-10-05, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2ffe15033567, moduleTitle=Ann Rheum Dis ：托珠单抗对糖皮质激素难治性成人still病的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2ffe15033567)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600358, encodeId=a2551600358ca, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Crit Care：脓毒性休克小儿糖皮质激素受体和皮质醇有何改变？, objectType=article, longId=150328, objectId=5f621503286b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5f621503286b, replyNumber=0, likeNumber=19, createdTime=2018-10-04, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5f621503286b, moduleTitle=Crit Care：脓毒性休克小儿糖皮质激素受体和皮质醇有何改变？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=5f621503286b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600357, encodeId=f066160035e55, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Cell Death Dis：伴侣蛋白60维持成骨细胞自噬并通过RPTOR抵消糖皮质激素加重骨质疏松症, objectType=article, longId=149523, objectId=fe1714952362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe1714952362, replyNumber=0, likeNumber=65, createdTime=2018-09-26, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe1714952362, moduleTitle=Cell Death Dis：伴侣蛋白60维持成骨细胞自噬并通过RPTOR抵消糖皮质激素加重骨质疏松症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fe1714952362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1600356, encodeId=4783160035621, content=<a href='/topic/show?id=3565e21649e' target=_blank style='color:#2F92EE;'>#皮质激素#</a>, objectTitle=Crit Care Med：重症脓毒症，糖皮质激素是否安全有效？, objectType=article, longId=149140, objectId=8e5f14914005, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=8e5f14914005, replyNumber=0, likeNumber=0, createdTime=2018-09-21, rootId=0, userName=bbwznl, userId=cb1a18781011, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=8e5f14914005, moduleTitle=Crit Care Med：重症脓毒症，糖皮质激素是否安全有效？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=8e5f14914005)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

皮质激素

2020-05-29

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Arthritis Rheumatol：狄诺塞麦与利塞膦酸盐对糖皮质激素诱导的骨质疏松症疗效的比较

2019-03-07

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

2019 BSH更佳实践指南：接受类固醇治疗的免疫血小板减少症患者糖皮质激素性骨质疏松症的预防

2019-02-03

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

2018 韩国指南：糖皮质激素性骨质疏松的预防和治疗

2018-12-31

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Biochem Biophys Res Commun：CircUSP45通过PTEN/AKT信号通路海绵miR-127-5p抑制糖皮质激素诱导的股骨头坏死

2018-12-28

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

常见风湿病中糖皮质激素的正确用法，你都知道吗？

2018-12-26

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Kidney Int：微小病变肾病综合征：低剂量糖皮质激素+麦考酚钠是否优于标准方案？

2018-12-20

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

J Thromb Haemost：缺血性卒中患者使用糖皮质激素心血管事件风险知多少

2018-12-10

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Ann Pharmacother：COPD急性加重：全身性糖皮质激素要联合ICS吗？

2018-12-10

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Health Technol Assess：儿童中耳炎听力受损口服糖皮质激素治疗有待推敲！

2018-12-06

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

JAMA：COPD急性加重控制病情低剂量茶碱可协助吸入性糖皮质激素？

2018-11-29

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

JCO：PD-1/PD-L1抑制剂初始治疗NSCLC 糖皮质激素让抗癌神药部分失效

2018-11-27

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

J Bone Miner Res：炎症疾病患者：糖皮质激素剂量极小能否逃脱骨折风险？

2018-11-24

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Diabetic Med：尿蛋白质组学和盐皮质激素受体拮抗预防2型糖尿病患者的糖尿病肾病

2018-11-18

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Sci Rep：糖皮质激素能够诱导前列腺癌细胞的治疗抗性相关的应激癌蛋白

2018-10-23

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

2018 SOGC临床实践指南：产前糖皮质激素治疗改善胎儿结局（No.364）

2018-10-15

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Laryngoscope：鼻用糖皮质激素不能导致眼部变化

2018-10-10

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Ann Rheum Dis ：托珠单抗对糖皮质激素难治性成人still病的疗效

2018-10-05

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Crit Care：脓毒性休克小儿糖皮质激素受体和皮质醇有何改变？

2018-10-04

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Cell Death Dis：伴侣蛋白60维持成骨细胞自噬并通过RPTOR抵消糖皮质激素加重骨质疏松症

2018-09-26

bbwznl (审核中...)

前往app查看评论内容

#皮质激素#

Crit Care Med：重症脓毒症，糖皮质激素是否安全有效？

2018-09-21

科室
- - 订阅+
  - 更多科室
工具
服务